| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |